Literature DB >> 31703793

Pain therapy - Are there new options on the horizon?

Christoph Stein1, Andreas Kopf2.   

Abstract

This article reviews the role of analgesic drugs with a particular emphasis on opioids. Opioids are the oldest and most potent drugs for the treatment of severe pain, but they are burdened by detrimental side effects such as respiratory depression, addiction, sedation, nausea, and constipation. Their clinical application is undisputed in acute (e.g., perioperative) and cancer pain, but their long-term use in chronic pain has met increasing scrutiny and has contributed to the current opioid crisis. We discuss epidemiological data, pharmacological principles, clinical applications, and research strategies aiming at novel opioids with reduced side effects.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Abuse; Bio-psycho-social; Chronic noncancer pain; Chronic nonmalignant pain; Inflammation; Misuse; Opiate; Opioid; Opioid crisis; Opioid receptor

Year:  2019        PMID: 31703793     DOI: 10.1016/j.berh.2019.06.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  3 in total

Review 1.  Dual Enkephalinase Inhibitors and Their Role in Chronic Pain Management.

Authors:  Warren A Southerland; Justin Gillis; Sumanth Kuppalli; Alex Fonseca; Andrew Mendelson; Storm V Horine; Nitin Bansal; Amitabh Gulati
Journal:  Curr Pain Headache Rep       Date:  2021-03-24

2.  Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking.

Authors:  Maria Dumitrascuta; Marcel Bermudez; Olga Trovato; Jolien De Neve; Steven Ballet; Gerhard Wolber; Mariana Spetea
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

Review 3.  Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-ones.

Authors:  Mariana Spetea; Helmut Schmidhammer
Journal:  Molecules       Date:  2021-09-18       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.